PAA 0.00% 19.5¢ pharmaust limited

Ann: Second Patient In Human Cancer Trial Begins Treatment, page-11

  1. 3,248 Posts.
    lightbulb Created with Sketch. 471
    The best part of this announcement is that if the screening of patient 3 and 4 goes well, then we will have completed the cohort for minimum dose and can now begin to look at higher dosage trials.
    The higher dosage trials will hopefully also bring with them some indications regarding efficacy too..
    Very happy to see boxes ticked
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.